Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic Potentials of Ketamine and Esketamine in Obsessive–Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature
Giovanni Martinotti, Stefania Chiappini, Mauro Pettorruso, et al.
Brain Sciences (2021) Vol. 11, Iss. 7, pp. 856-856
Open Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

The Neuropsychology of Anxiety
Neil McNaughton, Jeffrey A. Gray
Oxford University Press eBooks (2024)
Closed Access | Times Cited: 73
Real-world experience of esketamine use to manage treatment-resistant depression: A multicentric study on safety and effectiveness (REAL-ESK study)
Giovanni Martinotti, Antonio Vita, Andrea Fagiolini, et al.
Journal of Affective Disorders (2022) Vol. 319, pp. 646-654
Closed Access | Times Cited: 71
Redefining Ketamine Pharmacology for Antidepressant Action: Synergistic NMDA and Opioid Receptor Interactions?
Marjorie R. Levinstein, Reece C. Budinich, Jordi Bonaventura, et al.
American Journal of Psychiatry (2025)
Closed Access | Times Cited: 1
Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study
Stefania Chiappini, Giacomo d’Andrea, Sergio De Filippis, et al.
European Neuropsychopharmacology (2023) Vol. 74, pp. 15-21
Open Access | Times Cited: 28
Investigating the Effectiveness and Tolerability of Intranasal Esketamine Among Older Adults With Treatment-Resistant Depression (TRD): A Post-hoc Analysis from the REAL-ESK Study Group
Giacomo d’Andrea, Stefania Chiappini, Roger S. McIntyre, et al.
American Journal of Geriatric Psychiatry (2023) Vol. 31, Iss. 12, pp. 1032-1041
Open Access | Times Cited: 22
“This Is Something That Changed My Life”: A Qualitative Study of Patients' Experiences in a Clinical Trial of Ketamine Treatment for Alcohol Use Disorders
Özden Merve Mollaahmetoğlu, Johanna Louise Keeler, Katherine J. Ashbullby, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 40
Classic and non‐classic psychedelics for substance use disorder: A review of their historic, past and current research
Fúlvio Rieli Mendes, Cristiane dos Santos Costa, Victor Distefano Wiltenburg, et al.
Addiction Neuroscience (2022) Vol. 3, pp. 100025-100025
Open Access | Times Cited: 31
Therapies for obsessive-compulsive disorder: Current state of the art and perspectives for approaching treatment-resistant patients
Kevin Swierkosz-Lenart, João Flores Alves Dos Santos, Julien Elowe, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 21
Ketamine as a Treatment for Anorexia Nervosa: A Narrative Review
Johanna Louise Keeler, Janet Treasure, Mário F. Juruena, et al.
Nutrients (2021) Vol. 13, Iss. 11, pp. 4158-4158
Open Access | Times Cited: 38
Ketamine as a Novel Psychopharmacotherapy for Eating Disorders: Evidence and Future Directions
Anya Ragnhildstveit, Matthew Slayton, Laura Jackson, et al.
Brain Sciences (2022) Vol. 12, Iss. 3, pp. 382-382
Open Access | Times Cited: 22
First episode psychosis with and without the use of cannabis and synthetic cannabinoids: Psychopathology, global functioning and suicidal ideation
Valerio Ricci, Franca Ceci, Francesco Di Carlo, et al.
Psychiatry Research (2023) Vol. 320, pp. 115053-115053
Open Access | Times Cited: 15
Subanesthetic Ketamine Ameliorates Activity‐Based Anorexia of Adult Mice
Yiru Dong, Chiye Aoki
Synapse (2025) Vol. 79, Iss. 1
Closed Access
Is there a risk of esketamine misuse in clinical practice?
Carlos Roncero, M. Merizalde Torres, Néstor Szerman, et al.
Therapeutic Advances in Drug Safety (2025) Vol. 16
Open Access
Psychedelics in the Treatment of Substance Use Disorders and Addictive Behaviors: A Scoping Review
Jérémie Richard, Albert Garcia‐Romeu
Current Addiction Reports (2025) Vol. 12, Iss. 1
Closed Access
Temperature and Steric Hindrance-Regulated Selective Synthesis of Ketamine Derivatives and 2-Aryl-Cycloketone-1-Carboxamides via Nucleophilic Substitution and Favorskii Rearrangement
Haojiang Zhai, Penghui Li, Hongshuang Wang, et al.
Organic & Biomolecular Chemistry (2025)
Closed Access
Emerging strategies and clinical recommendations for the management of novel depression subtypes
Stefania Chiappini, Gaia Sampogna, Antonio Ventriglio, et al.
Expert Review of Neurotherapeutics (2025), pp. 1-21
Open Access
A case series of group-based ketamine-assisted psychotherapy for patients in residential treatment for eating disorders with comorbid depression and anxiety disorders
Reid Robison, Adèle Lafrance, Madeline Brendle, et al.
Journal of Eating Disorders (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 20
Comparative effectiveness of repeated ketamine infusions in treating anhedonia in bipolar and unipolar depression
Wei Zheng, Li-Mei Gu, Chen-Hui Sun, et al.
Journal of Affective Disorders (2021) Vol. 300, pp. 109-113
Closed Access | Times Cited: 23
Three daily intraperitoneal injections of sub‐anesthetic ketamine ameliorate activity‐based anorexia vulnerability of adult female mice
Sebastian Goodwin‐Groen, Yiru Dong, Chiye Aoki
International Journal of Eating Disorders (2023) Vol. 57, Iss. 7, pp. 1447-1464
Closed Access | Times Cited: 9
Comparison of K-Means, BIRCH and Hierarchical Clustering Algorithms in Clustering OCD Symptom Data
Alika Rahmarsyarah Rizalde, Haykal Alya Mubarak, Gilang Ramadhan, et al.
Deleted Journal (2024) Vol. 1, Iss. 2, pp. 102-108
Open Access | Times Cited: 3
Reward, relief, and habit drinking profiles in treatment seeking individuals with an AUD
Erica N. Grodin, Wave‐Ananda Baskerville, Lindsay R. Meredith, et al.
Alcohol and Alcoholism (2024) Vol. 59, Iss. 3
Open Access | Times Cited: 3
The association between ketamine and esketamine with alcohol and substance misuse: Reports to the Food and Drug Administration adverse event reporting system (FAERS)
Angela T.H. Kwan, Joshua D. Rosenblat, Rodrigo B. Mansur, et al.
Journal of Affective Disorders (2024) Vol. 360, pp. 421-426
Closed Access | Times Cited: 3
Cognitive changes in patients with unipolar TRD treated with IV ketamine: A systematic review
Verónica Grasso, Gilmar Gutiérrez, Najat Alzbeidi, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 135, pp. 111095-111095
Open Access | Times Cited: 3
Molecular mechanisms underlying the N-methyl-d-aspartate receptor antagonists: Highlighting their potential for transdiagnostic therapeutics
Christina Driver, Timothy N. W. Jackson, Jim Lagopoulos, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 119, pp. 110609-110609
Closed Access | Times Cited: 12
Ketamine and Zinc: Treatment of Anorexia Nervosa Via Dual NMDA Receptor Modulation
Jules Mitchell, Daniel F. Hermens, Maxwell R. Bennett, et al.
CNS Drugs (2023) Vol. 37, Iss. 2, pp. 159-180
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top